Home »
1994 Issues »
59 FR (07/19/1994) » 94-17448. National Toxicology Program; Availability of Technical Report on Toxicology and Carcinogenesis Studies of Oxazepam
94-17448. National Toxicology Program; Availability of Technical Report on Toxicology and Carcinogenesis Studies of Oxazepam
[Federal Register Volume 59, Number 137 (Tuesday, July 19, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-17448]
[[Page Unknown]]
[Federal Register: July 19, 1994]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Toxicology Program; Availability of Technical Report on
Toxicology and Carcinogenesis Studies of Oxazepam
The HHS' National Toxicology Program announces the availability of
the NTP Technical Report on the toxicology and carcinogenesis studies
of oxazepam, which is one of a number of benzodiazepines used
therapeutically as a sedative-hypnotic and antianxiety agent.
Toxicology and carcinogenesis studies were performed by
administering oxazepam (greater than 99% pure) to groups of 60 male and
60 female Swiss-Webster and B6C3F1 mice in feed at concentrations
of 0, 2,5000, or 5,000 ppm for 57 weeks (Swiss-Webster), or 2 years
(B6C3F1 ). Additional groups of 60 male and 60 female B6C3F1
mice received 125 ppm of oxazepam in feed to allow for concentrations
similar to those achieved in humans taking a therapeutic dose.
Under the conditions of these feed studies, there was clear
evidence of carcinogenic activity* of oxazepam in male and female
Swiss-Webster mice based on increased incidences of hepatocellular
adenoma and carcinoma. There was clear evidence of carcinogenic
activity of oxazepam in male and female B6C3F1 mice based on
increased incidences of hepatoblastoma and hepatocellular adenoma and
carcinoma. Increased incidences of hyperplasia of thyroid gland
follicular cells in male and female B6C3F1 mice and of follicular
cell adenomas in female B6C3F1 mice were also related to oxazepam
exposure.
---------------------------------------------------------------------------
*The NTP uses five categories of evidence of carcinogenic
activity observed in each animal study: two categories for positive
results (``clear evidence'' and ``some evidence''), one category for
uncertain findings (``equivocal evidence''), one category for no
observable effect (``no evidence''), and one category for studies
that cannot be evaluated because of major flaws (``inadequate
study'').
---------------------------------------------------------------------------
Administration of oxazepam to Swiss-Webster mice resulted in
centrilobular hepatocellular hypertrophy and increased incidences and
severity of systemic amyloidosis. Administration of oxyazepam to
B6C3F1 mice also resulted in centrilobular hepatocellular
hypertrophy.
Questions or comments about the Technical Report should be directed
to Central Data Management at P.O. Box 12233, Research Triangle Park,
NC 27709 or telephone (919) 541-3419.
Copies of Toxicology and Carcinogenesis Studies of Oxazeham (CAS
No. 604-75-1) in Swiss-Webster and B6C3F1 Mice (Feed Studies) (TR-
443) are available without charge from Central Data Management, NIEHS,
MD A0-01, P.O. Box 12233, Research Triangle Park, NC 27709; telephone
(919) 541-3419.
Dated: July 12, 1994.
Kenneth Olden,
Director, National Toxicology Program.
[FR Doc. 94-17448 Filed 7-18-94; 8:45 am]
BILLING CODE 4140-01-M
Document Information
- Published:
- 07/19/1994
- Department:
- Health and Human Services Department
- Entry Type:
- Uncategorized Document
- Document Number:
- 94-17448
- Pages:
- 0-0 (1 pages)
- Docket Numbers:
- Federal Register: July 19, 1994